EU medicines agencies reflect on lessons learned from COVID-19
https://www.ema.europa.eu/en/news/eu-medicines-agencies-reflect-lessons-learned-covid-19
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 27-30 November 2023
https://www.ema.europa.eu/en/news/meeting-highlights-pharmacovigilance-risk-assessment-committee-prac-27-30-november-2023
ANSM publishes the 2022 haemovigilance activity report
https://ansm.sante.fr/actualites/lansm-publie-le-rapport-dactivite-dhemovigilance-2022
PRAC recommendations on safety signals
https://www.ema.europa.eu/en/human-regulatory/post-authorisation/pharmacovigilance/signal-management/prac-recommendations-safety-signals
Getting ready for EMA’s website relaunch on 5 December 2023
https://www.ema.europa.eu/en/news/getting-ready-emas-website-relaunch-5-december-2023
Joint Action on Market Surveillance (JAMS) 2.0: Europe meets ANSM on 14 and 15 November 2023
https://ansm.sante.fr/actualites/joint-action-on-market-surveillance-jams-2-0-leurope-a-lansm-les-14-et-15-novembre-2023